NEUCA S.A. (WSE:NEU)
Poland · Delayed Price · Currency is PLN 657.00
+1.00 (0.15%)
Aug 13, 2025, 12:43 PM CET
Chimerix Market Cap
NEUCA has a market cap or net worth of 2.94 billion as of August 13, 2025. Its market cap has decreased by -21.34% in one year.
Market Cap
2.94B
Enterprise Value
3.82B
Revenue
12.82B
Ranking
n/a
PE Ratio
20.43
Stock Price
$657.00
Market Cap Chart
Since November 22, 2004, NEUCA's market cap has increased from 116.73M to 2.94B, an increase of 2,421.88%. That is a compound annual growth rate of 16.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 2.94B | -24.52% |
| Dec 30, 2024 | 3.90B | -4.37% |
| Dec 29, 2023 | 4.08B | 44.23% |
| Dec 30, 2022 | 2.83B | -23.49% |
| Dec 30, 2021 | 3.70B | 29.38% |
| Dec 30, 2020 | 2.86B | 79.60% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.72B |
| Voxel | 1.86B |
| Synektik Spólka Akcyjna | 1.81B |
| Celon Pharma | 1.22B |
| Ryvu Therapeutics | 709.79M |
| Selvita | 607.57M |
| Centrum Medyczne ENEL-MED | 559.95M |
| Bioceltix | 496.39M |